4.5 Article

Standards for epidemiologic studies and surveillance of epilepsy

Journal

EPILEPSIA
Volume 52, Issue -, Pages 2-26

Publisher

WILEY
DOI: 10.1111/j.1528-1167.2011.03121.x

Keywords

Epidemiology; Surveillance; Epilepsy

Funding

  1. Kedrion Pharma Company
  2. Eisai
  3. Sanofi-Aventis
  4. UCB Pharma
  5. GlaxoSmithKline
  6. UCB
  7. Dow Agro Science
  8. Ovation Pharmaceuticals
  9. Pfizer
  10. General Electric
  11. Amgen Inc.
  12. Genzyme
  13. Eli Lilly and Company
  14. Bristol Meyers Squibb
  15. Boerhringer-Ingelheim
  16. Astra Zeneca
  17. Cyberonics
  18. Esai
  19. Ortho McNeil
  20. Janssen-Gilag
  21. Novartis

Ask authors/readers for more resources

Worldwide, about 65 million people are estimated to have epilepsy. Epidemiologic studies are necessary to define the full public health burden of epilepsy; to set public health and health care priorities; to provide information needed for prevention, early detection, and treatment; to identify education and service needs; and to promote effective health care and support programs for people with epilepsy. However, different definitions and epidemiologic methods complicate the tasks of these studies and their interpretations and comparisons. The purpose of this document is to promote consistency in definitions and methods in an effort to enhance future population-based epidemiologic studies, facilitate comparison between populations, and encourage the collection of data useful for the promotion of public health. We discuss: (1) conceptual and operational definitions of epilepsy, (2) data resources and recommended data elements, and (3) methods and analyses appropriate for epidemiologic studies or the surveillance of epilepsy. Variations in these are considered, taking into account differing resource availability and needs among countries and differing purposes among studies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available